Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Everything you need to know about the Zika virus - from how it spreads to travel advice.
Tottenham have reached an agreement with the Football Association to play their European fixtures at Wembley next season.
The creatures feed on cherry trees, hawthorn and blackthorn and built the web to protect themselves from predators.